Expression, location, and interactions of ErbB2 and its intramembrane ligand Muc4 (sialomucin complex) in rat mammary gland during pregnancy
- 21 October 2004
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 203 (1) , 44-53
- https://doi.org/10.1002/jcp.20200
Abstract
Muc4 (also called Sialomucin complex) is a heterodimeric glycoprotein complex consisting of a peripheral O‐glycosylated subunit ASGP‐1 (ascites sialoglycoprotein‐1) tightly but non‐covalently bound to an N‐glycosylated transmembrane subunit ASGP‐2. Muc4/SMC can act as an intramembrane ligand for ErbB2 via an EGF‐like domain present in the transmembrane subunit. The complex is developmentally regulated in normal rat mammary gland and overexpressed in a number of mammary tumors. Overexpression of Muc4/SMC has been shown to block cell–cell and cell–matrix interactions, protect tumor cells from immune surveillance, promote metastasis, and protect from apoptosis. We have investigated whether Muc4/SMC and ErbB2 are co‐expressed and co‐localized in normal rat mammary gland and whether Muc4/SMC–ErbB2 complex formation is developmentally regulated in this tissue. Muc4/SMC and ErbB2 have different expression patterns and regulatory mechanisms in the developing rat mammary gland, but both are maximally expressed during late pregnancy and lactation. The two proteins form a complex in lactating mammary gland which is not detected in the virgin gland. Moreover, this complex does not contain ErbB3. ErbB2 is co‐localized with Muc4/SMC at the apical surfaces of ductal and alveolar cells in lactating gland; however, another form of ErbB2, recognized by a different antibody, localizes to the basolateral surfaces of these cells. ErbB2 phosphorylated on Tyr 1248 co‐localized with Muc4/SMC at the apical surface but not at the basolateral surfaces of these cells. To investigate the function of Muc4 in the mammary gland, transgenic mice were derived using an MMTV‐Muc4 construct. Interestingly, mammary gland development in the transgenic mice was aberrant, exhibiting a bifurcated pattern, including invasion down the blood vessel, similar to that exhibited by transgenic mice inappropriately expressing activated ErbB2 in the mammary gland. These data provide further evidence of the ability of Muc4/SMC to interact with ErbB2 and influence its behavior in normal epithelia.Keywords
This publication has 57 references indexed in Scilit:
- Muc4/Sialomucin Complex, the Intramembrane ErbB2 Ligand, Translocates ErbB2 to the Apical Surface in Polarized Epithelial CellsJournal of Biological Chemistry, 2003
- Differential localization of ErbB2 in different tissues of the rat female reproductive tract: Implications for the use of specific antibodies for ErbB2 analysisJournal of Cellular Physiology, 2001
- Sialomucin Complex (Rat Muc4) Is Regulated by Transforming Growth Factor β in Mammary Gland by a Novel Post-translational MechanismPublished by Elsevier ,2000
- Expression of dominant-negative ErbB2 in the mammary gland of transgenic mice reveals a role in lobuloalveolar development and lactationOncogene, 1999
- The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: from orphanhood to multiple stromal ligandsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1998
- Sialomucin Complex, a Heterodimeric Glycoprotein ComplexPublished by Elsevier ,1996
- Mammary organoids from immature virgin rats undergo ductal and alveolar morphogenesis when grown within a reconstituted basement membrane*1Experimental Cell Research, 1991
- Signal transduction by receptors with tyrosine kinase activityPublished by Elsevier ,1990
- Modulation of secreted proteins of mouse mammary epithelial cells by the collagenous substrata.The Journal of cell biology, 1984
- Effects of cytoskeletal perturbant drugs on ecto 5'-nucleotidase, a concanavalin A receptor.The Journal of cell biology, 1979